Cargando…
Dapagliflozin Alleviates Renal Fibrosis by Inhibiting RIP1-RIP3-MLKL-Mediated Necroinflammation in Unilateral Ureteral Obstruction
Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, offers renoprotection in diabetes. However, potential for use in nondiabetic kidney disease remains unknown. Herein, we assessed whether dapagliflozin alleviates renal fibrosis by interfering with necroinflammation in a rat model of unilater...
Autores principales: | Xuan, Mei Ying, Piao, Shang Guo, Ding, Jun, Nan, Qi Yan, Piao, Mei Hua, Jiang, Yu Ji, Zheng, Hai Lan, Jin, Ji Zhe, Li, Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777292/ https://www.ncbi.nlm.nih.gov/pubmed/35069210 http://dx.doi.org/10.3389/fphar.2021.798381 |
Ejemplares similares
-
Inhibition of RIP1-RIP3-mediated necroptosis attenuates renal fibrosis via Wnt3α/β-catenin/GSK-3β signaling in unilateral ureteral obstruction
por: Piao, Shang Guo, et al.
Publicado: (2022) -
Up-Regulation of RIP3 Alleviates Prostate Cancer Progression by Activation of RIP3/MLKL Signaling Pathway and Induction of Necroptosis
por: Wang, Ke-jie, et al.
Publicado: (2020) -
RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin
por: Shrestha, Archana, et al.
Publicado: (2019) -
RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage
por: Zhou, Huiling, et al.
Publicado: (2020) -
RIP1/RIP3/MLKL Mediates Myocardial Function Through Necroptosis in Experimental Autoimmune Myocarditis
por: Wu, Yujing, et al.
Publicado: (2021)